Central lung inflammatory myofibroblastic tumor after aspergillosis and total occlusion of the left pulmonary artery

Submitted: 12 October 2023
Accepted: 25 October 2023
Published: 26 October 2023
Abstract Views: 1517
PDF: 62
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Inflammatory Myofibroblastic Tumor (IMT) is a benign tumor that is extremely rare. We present a 54-year-old man who has received 23 years of conservative treatment for IMT, respiratory infections, aspergillosis, and hemoptysis. A left intrapericardial pneumonectomy was performed with efficacy. The left atrial auricle lesion created a massive hemorrhage during chest closure due to contact with the staplers of the left pulmonary artery stapler line. The hemorrhaging was stopped immediately. The patient has entirely recovered one year after surgery, and no adverse events or relapses have occurred.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

World Health Organization (WHO). Soft tissue and bone tumors. WHO classification of tumors, 5th edition, volume 3. 2013. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Soft-Tissue-And-Bone-Tumours-2020
Braham Y, Migaou A, Njima M, et al. Inflammatory myofibroblastic tumor of the lung: A rare entity. Respiratory Medicine Case Reports 2020;31:101287. DOI: https://doi.org/10.1016/j.rmcr.2020.101287
Iyer A, Radonic T, Hecamp LC, et al. Inflammatory myofibroblastic tumor of the central airways: treatment and molecular analysis. ERJ open research 2021;7:00151-2020. DOI: https://doi.org/10.1183/23120541.00151-2020
Yüksel C, Yenigün BM, Kocaman G, et al. Operated pulmonary inflammatory myofibroblastic tumors: Our experience with 17 cases. Turk Gogus Kalp Damar Cerrahisi Derg 2022;30:101-8. DOI: https://doi.org/10.5606/tgkdc.dergisi.2022.21263
Hammas N, Chbani L, Rami M, et al. A rare tumor of the lung: inflammatory myofibroblastic tumor. Diagnostic Pathology 2012;7:83. DOI: https://doi.org/10.1186/1746-1596-7-83
Camela F, Gallucci M, Di Palmo E, et al. Pulmonary inflammatory myofibroblastic tumor in children: A case report and brief review of literature. Frontiers in Pediatrics 2018;6:35. DOI: https://doi.org/10.3389/fped.2018.00035
Sakurai H, Hasegawa T, Watanabe S, et al. Inflammatory myofibroblastic tumor of the lung. European Journal of Cardio-Thoracic Surgery 2004;25:155-9. DOI: https://doi.org/10.1016/S1010-7940(03)00678-X
Seyedi S-J, Saeidinia A, Dehghanian P. Pulmonary inflammatory myofibroblastic tumor in a male child: A case report. Clinical Case Reports 2022;10:e6003. DOI: https://doi.org/10.1002/ccr3.6003
Amir R, Danahey D, Ferrer K, et al. Inflammatory myofibroblastic tumor presenting with tracheal obstruction in a pregnant woman. Am J Otolaryngol 2002;23:362-7. DOI: https://doi.org/10.1053/ajot.2002.128041
Browne CP, Zeman-Pocrnich C, Dar AR, et al. A Rare Case of Inflammatory Myofibroblastic Tumor Causing Left Pulmonary Artery Stenosis and Successfully Treated with Localized Radiotherapy in a Patient with Perinuclear Antineutrophil Cytoplasmic Antibody Vasculitis. Cureus 2020;12:e6709. DOI: https://doi.org/10.7759/cureus.6709

How to Cite

Yankov, G., Aleksieva, M., Keltchev, A., & Mekov, E. (2023). Central lung inflammatory myofibroblastic tumor after aspergillosis and total occlusion of the left pulmonary artery. Chest Disease Reports, 11(1). https://doi.org/10.4081/cdr.11.11957